OTCMKTS:APNHY Aspen Pharmacare (APNHY) Stock Price, News & Analysis $6.99 +0.22 (+3.27%) As of 07/3/2025 10:41 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesShort InterestBuy This Stock About Aspen Pharmacare Stock (OTCMKTS:APNHY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aspen Pharmacare alerts:Sign Up Key Stats Today's Range$6.99▼$6.9950-Day Range$6.00▼$6.9952-Week Range$5.76▼$13.69Volume122 shsAverage Volume250 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield1.72%Price TargetN/AConsensus RatingN/A Company Overview Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa. Read More Receive APNHY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspen Pharmacare and its competitors with MarketBeat's FREE daily newsletter. Email Address APNHY Stock News HeadlinesAspen Pharmacare Holdings Ltd. ADR (APNHY) Stock Price Today - WSJ - The Wall Street JournalJuly 2 at 7:34 AM | wsj.comAspen Pharmacare Holdings Limited (APN.JO) - Yahoo FinanceJuly 1, 2025 | nz.finance.yahoo.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.July 5 at 2:00 AM | Brownstone Research (Ad)Aspen Pharmacare Holdings Limited (APNHY) - Yahoo FinanceJune 26, 2025 | sg.finance.yahoo.comAnalyzing Aspen Pharmacare (OTCMKTS:APNHY) and BridgeBio Pharma (NASDAQ:BBIO)June 26, 2025 | americanbankingnews.comInvestors in Aspen Pharmacare Holdings (JSE:APN) have unfortunately lost 46% over the last yearJune 10, 2025 | finance.yahoo.comAPNHY Aspen Pharmacare Holdings LimitedJune 6, 2025 | seekingalpha.comAspen Pharmacare Holdings LtdMay 27, 2025 | morningstar.comMSee More Headlines APNHY Stock Analysis - Frequently Asked Questions How have APNHY shares performed this year? Aspen Pharmacare's stock was trading at $8.26 on January 1st, 2025. Since then, APNHY shares have decreased by 15.4% and is now trading at $6.9915. How do I buy shares of Aspen Pharmacare? Shares of APNHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today7/05/2025Next Earnings (Estimated)9/03/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - GENERIC DRG Sub-IndustryN/A Current SymbolOTCMKTS:APNHY Previous SymbolNASDAQ:APNHY CIK1454177 Webwww.aspenpharma.com Phone(731) 580-8600Fax27-11-239-6144Employees9,350Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.36 Current Ratio2.35 Quick Ratio1.25 Sales & Book Value Annual Sales$2.39 billion Price / SalesN/A Cash Flow$1.07 per share Price / Cash Flow6.55 Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.96 Social Links 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (OTCMKTS:APNHY) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Pharmacare Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspen Pharmacare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.